Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus

Fig. 4

Serum FSTL3 partially mediated the association of increased fibrosis risk and AMI in NAFLD and T2DM patients. A, C: When stratified according to NFS/FIB-4, and before adjusting for other relevant variables, the mediating effect of serum FSTL3 on association of increased fibrosis risk with AMI. B, D: When stratified according to NFS/FIB-4, and after adjusting for sex, artery hypertension, smoking, waist circumference and eGFR, the mediating effect of serum FSTL3 on association of increased fibrosis risk with AMI

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840